Calcium handling in human heart failure-Abnormalities and target for therapy

Wiener Medizinische Wochenschrift

Volumn 162, Issue 13-14, 2012, Pages 297-301

  Reuter, Hannes ^a   Schwinger, Robert H G ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Ca2+ handling; Gene therapy; Heart fai lure; Levosimendan; Ranolazine

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; DIGITALIS; ISTAROXIME; LEVOSIMENDAN; RANOLAZINE; RECEPTOR PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DIASTOLE; DRUG MECHANISM; DRUG TARGETING; EXCITATION CONTRACTION COUPLING; FEASIBILITY STUDY; GENE THERAPY; HEART FAILURE; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STABLE ANGINA PECTORIS; SYSTOLE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM-BINDING PROTEINS; DIASTOLE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; GENETIC THERAPY; HEART FAILURE; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOFIBRILS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOLEMMA; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER; SYSTOLE;

EID: 84864476166     PISSN: 00435341     EISSN: 1563258X     Source Type: Journal    
DOI: 10.1007/s10354-012-0117-9     Document Type: Review

References (14)

1. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983;245:C1-14.
2. Matthes J, Jager A, Handrock R, et al. Ca2+-dependent modulation of single human cardiac L-Type calcium channels by the calcineurin inhibitor cyclosporine. J Mol Cell Cardiol. 2004;36:241-55. (Pubitemid 38202353)
3. Satin J, Schroder EA, Crump SM. L-Type calcium channel auto-regulation of transcription. Cell Calcium. 2011;49:306-13.
4. Yano M, Ono K, Ohkusa T, et al. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation. 2000;102:2131-6.
5. Kho C, Lee A, Jeong D, et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature. 2011;477:601-5.
6. Schwinger RH, Munch G, Bolck B, et al. Reduced Ca(2+)-sensitivity of SERCA2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol. 1999;31:479-91. (Pubitemid 29121635)
7. Lou Q, Fedorov VV, Glukhov AV, et al. Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation. 2011;123:1881-90.
8. Reuter H, Henderson SA, Han T, et al. The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides. Circ Res. 2002;90:305-8. (Pubitemid 34633932)
9. Chaitman BR, Skettino SL, Parker JO, et al. Anti-ischemic effects and long-Term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol. 2004;43:1375-82. (Pubitemid 38496341)
10. Cleland JG, Freemantle N, Coletta AP, et al. Clinical trials update from the American Heart Association: REPAIRAMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail. 2006;8:105-10. (Pubitemid 43012109)
11. Nieminen MS, Cleland JG, Eha J, et al. Oral levosimendan in patients with severe chronic heart failure-The PERSIST study. Eur J Heart Fail. 2008;10:1246-54.
12. Gheorghiade M, Blair JE, Filippatos GS, et al. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: A randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008;51:2276-85.
13. Jessup M, Greenberg B, Mancini D, et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation. 2011;124:304-13.
14. Tang T, Gao MH, Roth DM, et al. Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Am J Physiol Heart Circ Physiol. 2004;287:H1906-12. (Pubitemid 39430724)